Running head: NONINVASIVE VENTILATION PROTOCOL DEVELOPMENT

Noninvasive Ventilation Protocol Development
A Scholarly Project
Submitted to the
Faculty of Liberty University
in partial fulfillment of
the requirements for the degree
of Doctor of Nursing Practice
By
Janise P. Tinsman
Liberty University
Lynchburg, VA
October 2019

2
NONINVASIVE VENTILATION PROTOCOL DEVELOPMENT
Noninvasive Ventilation Protocol Development
A Scholarly Project
Submitted to the
Faculty of Liberty University
in partial fulfillment of
the requirements for the degree
of Doctor of Nursing Practice
By
Janise P. Tinsman
Liberty University
Lynchburg, VA
August 2019

Scholarly Project Chair Approval:

Cynthia Goodrich, EdD, MSN, RN, CNE

3
NONINVASIVE VENTILATION PROTOCOL DEVELOPMENT
Abstract
Endotracheal intubation results in many serious complications including regurgitation, vocal
cord paralysis, and death. Noninvasive ventilation using bi-level positive airway pressure has
been shown to provide the necessary support without intubation and is also associated with better
outcomes if trialed prior to endotracheal intubation. A noninvasive ventilation protocol was
applied in a rural acute care facility. Results: The average length of stay for acute respiratory
failure decreased from 5.32 to 4.44 days, while intubations fell from 41.9% to zero, and mortality
fell from 9.7% to zero during the pilot period. Five cases met criteria for noninvasive
ventilation, and three received prompt intervention with lengths of stay of two to four days. One
did not have CO2 levels assessed upon admission resulting in delayed noninvasive ventilation,
and a twelve-day stay. The fifth refused the therapy and was discharged on hospice.
Keywords: noninvasive ventilation, protocols, endotracheal intubation
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Noninvasive Ventilation Protocol Development
Section One
Background
Endotracheal intubation (ETI) is associated with many serious complications including
hypoxemia, laryngospasm, airway edema, vocal cord paralysis, regurgitation, cardiovascular
collapse, and even cardiac arrest. Patients that present to the hospital in acute respiratory distress
or failure have been shown to respond well to noninvasive ventilation (NIV), decreasing the risk
of serious trauma from intubation. The Canadian Critical Care Society has developed guidelines
for NIV trials prior to invasive ETI. The Infectious Disease Society of America (IDSA) and the
American Thoracic Society (ATS) joint guidelines for community acquired pneumonia (CAP)
includes a recommendation for NIV protocols. NIV has been proven useful in the management
of acute respiratory failure (ARF) associated with chronic obstructive pulmonary disease
(COPD) and cardiogenic pulmonary edema (CPE). Development of NIV protocols led to a
decrease in the number of ETIs performed, decreasing the trauma associated with this procedure.
Use of NIV often resolves the respiratory failure, allows for patient communication and oral
intake of nutrition, and supports the patient’s respirations rather than taking over the work of
breathing.
The facility under study began investigating its respiratory care practices related to a
report of higher than expected 30-day pneumonia mortality rates. A gap analysis of the
IDSA/ATS guidelines was conducted, with multiple gaps found, including the lack of NIV
protocols, which could impact not only pneumonia survival rates, but COPD and CPE outcomes
as well. NIV is shown to be effective in ARF with hypoxia, a decreased level of oxygen in the
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blood, and hypercapnia, an elevated level of carbon dioxide (CO2) in the blood. These levels are
most accurately measured via arterial blood gas (ABG) measurement.
Historical data was collected on 31 admissions with a diagnosis of ARF between
December 27, 2018, and April 12, 2019. Fifteen patients reviewed received ETI with twelve of
these occurring in the Emergency Department (ED). The twelve ED intubations recorded two
NIV trials prior to intubation, and one patient refusing to keep the NIV mask in place prior to
intubation. One patient arrived in the ED already intubated by the Emergency Medical Services
team. One patient was intubated in the OR and arrested in the OR. One patient was in the
intensive care unit (ICU) and on NIV for two days prior to intubation. One patient who was not
hypercapnic in the beginning of their course of treatment placed on NIV for five days with no
follow up ABGs and arrested on the fifth day with a PaCO2 of 81.7, with normal values for
PaCO2 at 35-45. Four patients with hypercapnia were managed with NIV alone and were not
intubated. Establishment of a protocol for monitoring patient response to NIV could prevent the
event described above, as periodic monitoring of ABGs would catch the change in PaCO2 to
allow intervention before respiratory arrest. Trialing of NIV when possible prior to ETI would
reduce the potential damage from the invasive procedure and decrease LOS.
Problem Statement
Lack of an NIV protocol can lead to inconsistent application of this therapy, placing
patients at risk for failure to rescue or complications from unnecessary ETI. NIV protocols
provide guidelines for consideration of NIV as well as indications for ETI. These guidelines will
improve outcomes for patients in ARF.
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Purpose of the Project
The purpose of the project is determination of NIV protocols to prompt for rapid
application of this therapy in appropriate situations and reduction in the number ETIs for ARF.
The NIV protocol is expected to reduce the rate of failure to rescue and ETI in adult ARF
patients with improved patient outcomes, including decreased length of stay (LOS) and mortality
rates.
Clinical Question
For adult patients presenting to a rural Texas acute care facility with acute respiratory
failure (ARF), will a noninvasive ventilation (NIV) protocol decrease the rate of failure to
rescue, the number of endotracheal intubations (ETIs), length of stay (LOS), and mortality rates.
Section Two: Literature Review
Search Strategy
A search was conducted using CINAHL, MEDLINE PLUS, the Cochrane Library, and
ProQuest Health and Medical Collection databases. Search terms included noninvasive
ventilation (NIV), noninvasive positive pressure ventilation (NPPV), acute respiratory failure
(ARF), endotracheal intubation (ETI), and protocols. Twenty-one articles were selected and
examined using the Melnyk Levels of Evidence Table. Eighteen studies and articles were found
to support the project. Two were studies that were in progress with no results available at the
time of the literature search, and three involved equipment or personnel not available in the
facility of study.
Critical Appraisal
Six of the studies included were published between 2011 and 2013, with four of these
being Level I systematic reviews or practice guidelines. The remaining studies were published
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in the past five years. Nine of the studies included in the review are Level I evidence as
systematic reviews, meta-analyses, or practice guidelines, seven of which support the use of NIV
in reduction of ETI and mortality in ARF. There are two Level II randomized controlled trials
that address the issue but are ongoing with no results available. Four Level IV cohort studies are
included, two of which indicate ARF patients provided a trial of NIV prior to ETI experience
better outcomes than patients intubated without NIV trial. One Level V qualitative analysis is
included which also supports NIV in the reduction of ETI. Four Level VI studies are included,
one supporting NIV for treatment of ARF in underlying COPD and CPE, one discussing
humidification in NIV, one comparing individual physician controlled noninvasive positive
pressure ventilation (iNPPV) and protocol-driven noninvasive positive pressure ventilation
(pNPPV), and one examining the role of the physiotherapist in NIV management. Two Level
VII expert opinion articles were included supporting the need for NIV protocols and training of
staff in appropriate use.
Synthesis
NIV is shown to be associated with a decreased rate of ETI, protecting patients from the
trauma involved in this invasive therapy (Digby, 2015; Liu, Zhao, & Tang, 2016; Osadnik et al.,
2017; Ouellette et al., 2017; Scala & Pisana, 2018). NIV is supported for use in ARF in the
presence of chronic illnesses such as COPD and CPE (Burns, Meade, Premji & Adhikari, 2013;
Keenan et al., 2011; Stefan et al., 2018; Vargas et al., 2017). Berg and Donnino (2012) support
the use of NIV for pneumonia associated ARF, while Lim et al. (2012) found controversial data
for use of NIV in asthmatic clients. Bersten (2011) and Equinas et al. (2014) support the need for
protocols and staff training in the use of NIV. Kikichi et al. (2011) investigated outcomes
between individual physician-directed noninvasive positive pressure ventilation (iNPPV) and
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protocol-based NPPV (pNPPV), finding pNPPV to reduce the time to intubation and to reduce
group and hospital mortality.
The remaining studies address specific aspects of NIV therapy that could inform
development of an NIV protocol. Alqahtani, Worsley, and Voegeli (2018) found that humidity
in NIV increased the development of skin breakdown. BaHammam, Singh, Gupta, Pandi, and
Perunal (2018) found full-face and oronasal masks preferable to nasal masks in the acute stage,
with weaning to oronasal appropriate after stabilization. Brambilla et al., (2019) suggest a
continuous positive airway pressure (CPAP) trial for hypoxic nonhypercapnic ARF, with shift to
NPPV if response is poor. Meeder, Tjan, and Zanten (2016) recommend an NPPV prior to ETI
as those patients receiving NPPV prior to ETI had better outcomes than those initially intubated
without NPPV. Ouellette et al. (2017) recommend spontaneous breathing trials (SBT) for those
intubated greater than 24 hours with CPAP, minimal sedation, and NIV post extubation to
prevent weaning failure. Ni, Wang, Tu, Liang, and Liang (2017) suggest that NPPV interface
intolerance post extubation can be managed with sedation and analgesia.
Four studies are not applicable to the proposed project. Burns, Lelloch, Wisenbaum,
Lessard, and Friedrich (2014) discussed the SmartCare automated weaning system that is not
available at the facility of study. Simonelli, Paneroni, and Vitacca (2013) discussed the role of
the physiotherapist in NIV therapy, and no physiotherapists are available in the facility of study.
The two randomized controlled trials described appropriate questions of interest but had not been
completed at the time of the search. Therefore no evidence was available to inform the project.
Conceptual Model
The Iowa Model June 2015 Revision: Evidence-Based Practice to Promote Excellence in
Health Care, hereafter referred to as the Iowa Model, was applied to the project. The Iowa
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Model consists of a triggering issue with a question to be explored. A quality improvement team
is then formed to address the question with deliberate consideration of the appropriate disciplines
to be included on the team. Collection of historical data within the facility connected with the
practice question formed a comparison group for improvement. Research into the body of
evidence surrounding the practice question was done as described above to determine best
practice. The team designed and implemented a pilot practice change, monitored patient
outcomes, and compared them to the historical data previously collected.
The triggering issue for the project was the preliminary gap analysis identifying lack of a
noninvasive ventilation (NIV) protocol. The question to be explored was whether an NIV
protocol would reduce the number of ETIs, mortality rates, and length of stay (LOS) for all adult
ARF patients. The NIV protocol development team (NIV-PDT) included the project leader,
respiratory therapy department head, respiratory therapists, the chief hospitalist, the nurse
manager of ICU, the nurse informaticist, the Chief Nursing Officer, and the Director of
Operations. A literature review was performed as described above informing the development of
a protocol by the NIV-PDT. Historical data regarding NIV, ETI, and patient outcomes had been
collected by the project leader for comparison against project outcomes. The pilot protocol
developed by the team was approved and education of respiratory therapists, nurses, and
physicians followed. The protocol was implemented for eight weeks in the ED, ICU, and
Medical/Telemetry units. NIV, ETIs, LOS, and mortality rates for adult patients admitted with
ARF were collected over the course of the pilot and reported upon conclusion of the pilot. The
results were provided to the pulmonary medicine director to inform any modifications desired for
a standing protocol. Integration and sustainability of the NIV protocol will be achieved through
policy revisions supporting the establishment of an official NIV protocol and policy for the
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facility. Dissemination of the results may occur at the corporate level for sister facilities within
the corporation. Results will also be presented as the project defense by the project leader and
posted in the Liberty University Digital commons.
Summary
The IDSA/ATS guidelines for CAP and the CCCS guidelines for NIV support the
development of NIV protocols. Recent research further supports preliminary NIV trials prior to
ETI and standardization of care. The IDSA/ATS gap analysis performed by the facility revealed
the lack of a NIV protocol. A quality improvement team was formed to address this gap and
develop said protocol. Improvement of patient outcomes, specifically decreased number of
ETIs, LOS, and mortality rates for adult ARF patients, were monitored and compared to preproject data.
Section Three: Methodology
Design
The study was an evidence-based practice (EBP) project utilizing a quasi-experimental
approach to gather and analyze data. Examination of the effect of NIV protocols on the rate of
ETI and mortality and LOS for adult ARF patients was performed. Data gathered was shared
during the project and upon completion. Data was also compared to historical data collected
before implementation of the protocol.
Measurable Outcomes
The variables of interest include the rate of ETI, average LOS, and mortality rates for
adult patients admitted with ARF. The lack of NIV protocols has resulted in a variety of
individual physician-directed methods of treatment rather than a standardized approach to care.
Development of a protocol was expected to decrease ETIs, LOS, and mortality rates for adult
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ARF patients. The protocol was also expected to decrease the incidence of failure to rescue in
this patient population.
Setting
The project was implemented in a rural Texas hospital with a 15-bed ED, 12 ICU beds
and 36 Medical/Telemetry beds. The organizational culture welcomes EBP initiatives and
quality improvement projects. Adults in ARF will first be seen in the ED and determination
regarding ventilation and response to treatment evaluated. The NIV protocol would be critical at
this juncture of care. NIV could continue in the ICU and Medical/Telemetry units necessitating
protocols for these areas as well. NIV is also used as part of the ETI weaning process in the
ICU, and established standards could improve the patient experience and outcomes there.
Permission to pursue the NIV protocol was granted by the facility and can be found in the
appendix.
Population
The population of study included all adult ARF patients treated in the facility during an
eight-week period after protocol initiation. Asthma patients were excluded due to lack of
evidence of the efficacy of NIV in this population. The hospitalists, along with the respiratory
therapists, and nurses in ICU, ED, and Medical/Telemetry were educated regarding the protocol.
Documentation indicating protocol implementation, along with ETI, LOS, and mortality for this
population were evaluated.
Ethical Considerations
The risk to the patients was reduced through implementation of the protocol, designed to
initiate less invasive ventilation prior to ETI. All ARF patients received this evidence-based
standard of care, with the historical data serving as the control group. Decreased numbers of
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ETIs reduces the complications seen with invasive intubation. The project leader and Chair have
completed the CITI training for the protection of human subjects.
Data Collection
Chart reviews were performed to ascertain adherence to the pilot NIV protocol. Patient
response to NIV, incidence of ETI, LOS, and mortality rates were also gathered. Data was shared
with the NIV-PDT upon project completion. This data was compared to the historical data
collected prior to the protocol.
Tools
The major tool for the project is the NIV protocol developed by the NIV-PDT. An audit
tool for collection of data for ARF patients, including the ventilation support used, the LOS, and
the mortality rate, was used for historical data collection. ARF patient charts were audited with
the same tool after initiation of the protocol. An educational presentation was given to the
hospitalist group providers, respiratory therapists, and nurses in ED, ICU, and
Medical/Telemetry units regarding their roles, and the necessity for and implementation of the
protocol. The ED providers group was new to the facility and just adjusting to their new
environment and were not included in the education.
Intervention
The lack of NIV protocols results in inconsistent care for adult ARF patients. Education
of providers, RTs, and nurses involved in implementation was provided regarding the use of the
protocol and the rationale behind the development of the protocol. Implementation of an NIV
protocol developed by the NIV-PDT was performed over an eight-week period.
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Data Analysis
Historical and post pilot protocol data were analyzed using descriptive statistics to assist
in finding trends that support the continued use of the protocol. Implementation of the protocol
was expected to decrease the number of ETIs and the associated complications. ARF patient
LOS and mortality were also expected to decrease with the protocol.
Section Four: Results
Descriptive Statistics
The measurable outcomes of percentage of ETI, average LOS, and mortality were
compared between the historical and pilot groups with the results displayed in Table 1. There
was improvement noted in all three measures among the pilot group. The percentage of ARF
patients intubated in the historical group was 48.4%, while there were no intubations in the pilot
group. The average LOS for the historical group was 5.32 days, and the pilot group average
LOS was 4.44 days. There was a 9.7% mortality rate among the historical group, with no
mortalities occurring in the pilot group. Of the thirty-six pilot patients, six were placed on
hospice for end-of-life care, but there were no deaths during the acute inpatient stay. The results
support the use of protocols for respiratory and ventilatory support.

Table 1
Comparison of Measurable Outcomes
Outcome

Historical

Pilot

Percentage of endotracheal intubations

48.4%

0

Average Length of Stay (LOS)

5.32 Days

4.44 Days

Mortality rate

9.7%

0
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______________________________________________________________________________
Protocol adherence and patient response were also monitored during the pilot. Twelve of
the thirty-six patients were hypercapnic, and five of those twelve were also acidotic, prompting
for initiation of the NIV protocol. BiPAP was initiated immediately for three of the five, with
one patient refusing the therapy. The remaining patient did not have an ABG drawn until day
four of the stay. On day five, Vapotherm, a warmed, humidified, and pressure regulated highflow nasal cannula delivery, was initiated, followed by BiPAP. The hospital course continued
over seven more days before the patient was transferred to a long-term acute care (LTAC)
facility. Table 2 displays the course of these five patients for whom the protocol applied.
Table 2
Protocol Applicable Patient Course
Pt ID pH
PCO2 Support
Recheck
LOS Disposition
______________________________________________________________________________
P-3
7.25 48
2L/NC
5 Hours
12
Transfer to LTAC
P-7
7.22 72
BiPAP
2.5 Hours
4
Discharge with O2
P-11 7.33 57.1 BiPAP
5 Hours
2
Home with Home Health
P-26 7.30 87.5 3L/NC
17 Hours
3
Home on Hospice
P-33 7.29 68.3 BiPAP
2 Hours
3
Home with trilogy for OSA
_____________________________________________________________________________
The additional respiratory support therapy implemented in the pilot group known as
Vapotherm was not addressed in the pilot protocol. Two pilot patients received Vapotherm
alone, three received alternating Vapotherm and BiPAP, and three received BiPAP alone. Only
one of the hypercapnic, acidotic patients received this therapy as described above.
Section Five: Discussion
Implications for Practice
The results of this pilot project support the use of protocols for NIV and other respiratory
support therapies. Uniform application of evidence-based practice yields improved patient
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outcomes, as well as improved team morale. Consistent delivery of care removes uncertainty
among team members regarding implementation and evaluation of care. Protocols for respiratory
support allow for more rapid application of these therapies by the respiratory therapists and
nurses, thus removing the time element of contacting a provider for orders. Treatment options
such as NIV that have been shown to positively impact patient outcomes can be initiated upon
initial assessment by respiratory therapists if the patient meets the set criteria. Protocols should
indicate time frames for evaluation of the patients and indications for continued therapy or
consideration of ETI. The historical group included a patient that was on BiPAP for five days
without evaluation of respiratory status via arterial blood gases (ABGs). When this patient
arrested, the PaCO2 was 81.7, well above the normal 35–45 range. This could have been avoided
if a protocol prompting for periodic evaluation of patients on ventilatory support had been in
place. During the interim between the historical study and the pilot project, a patient came into
the emergency department with ARF and was placed on BiPAP. When the admitting provider
evaluated the patient, the patient was able to answer questions without evidence of respiratory
distress, and the BiPAP was discontinued. A few hours later, the patient arrested on the
Medical/Telemetry unit. A protocol that called for at least 12 hours of NIV therapy and a
reassessment by ABGs prior to discontinuation could have prevented this situation as well.
The use of Vapotherm requires additional study and investigation. There are very few
studies regarding the use of this therapy in adults. The recommendations for use are provided
from studies performed by the manufacturer rather than an impartial researcher. For the
hypercapnic, acidotic patient, this therapy was found to be less effective than BiPAP. The
facility could perform their own study of the effectiveness of this therapy and develop guidelines
for application of this intervention.
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Limitations of the project include the application in a single small facility with sample
sizes less than forty patients for both groups. The time frame of the historical data was during
the first months of the year when there typically are more cases of respiratory infections;
however, the protocol period evidenced a slightly higher number of ARF patients. The small
sample size of five ARF patients with both hypercapnia and acidosis limits applicability of
results to further studies. The pilot time frame was also limited to two months for data
collection, further decreasing the generalizability of the results.
Sustainability
The results of the study and research into appropriate use of the Vapotherm therapy have
been shared with the pulmonary medical director. A formal protocol is to be developed by the
facility providers including the ED physicians and representatives from the respiratory therapy
department. The protocol will provide parameters for initiation of various oxygen/ventilatory
support therapies. Institution of such a policy will free respiratory therapists to initiate
oxygen/ventilatory support without taking time to obtain an order from the providers. Patients
will receive these critical therapies sooner and recovery times will be decreased. The protocol
should also address evaluation parameters for patients with ventilatory support, allowing for
weaning or adapting therapy according to individual patient response.
Dissemination Plan
The NIV Protocol Project will be submitted to the Liberty University Scholars Crossing.
A poster presentation and Podium presentations have also been prepared for sharing these
results. The results have been shared with the Director of Quality Management and Regulatory
Compliance for report to the corporate superiors. The results may then be shared with sister
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facilities within the corporation. Poster and podium presentations have been prepared, as well as
a manuscript for potential publication.
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Appendix A: Evidence Table
Article Title,
Author

Study Purpose

Alqahtani, J.
S., Worsley, P.,
& Voegeli, D.
(2018)

Determine the
effect on
humidification of
CPAP the skin
microclimate,
barrier function,
and risk of
pressure ulcer
development

BaHammam,
A. S., Singh, T.
D., Gupta, R.,
Pandi-Perumal,
S. R., (2018)

Investigation of
different
interfaces for NIV
and their effect on
treatment success,
upper airway
patency, mask
fitting, and
interface related
problems

Sample
Characteristics

Methods

Study Results

Fifteen healthy
volunteers

A crossover
cohort design.
Transepithelial
water loss, skin
hydration and
pH at the bridge
of the nose and
both cheeks
after both nonhumidified and
humidified
CPAP therapy

Humidified NIV
was shown to have
a higher risk of
breakdown and
disruption of the
interface, while
non-humidified
therapy resulted in
elevated nasal
discomfort

80 studies
comparing
interfaces during
NIV during
acute respiratory
failure ARF
were reviewed
and summarized

Systematic
review

Oronasal and face
masks are preferred
for ARF. Fitting to
prevent air leaks
and skin irritation
is needed for
successful NIV
therapy. Shifting to
nasal mask may be
done when
stabilized, but
patient preference
must be accounted
for. The helmet is a

Level of
Evidence

Study
Limitations

Supports
Practice
Change

Level VI
Single
descriptive
study

Small sample of
only 15 healthy
adults. Many
who require NIV
have multiple
health challenges

Yes.
Withholding
humidity could
be included in
the protocol

Level I
Systematic
review

Multiple studies
reviewed
comparing
multiple NIV
interfaces

Yes.
Stabilization on
Full face or
oronasal mask
for ARF could
be included in
the protocol
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Berg, K. M.,
Donnino, M.
W., (2012)

Examination of
the evidence
supporting NIV,
the potential
dangers, and
guidelines for use

Forty-four
studies/articles
involving NIV
in ARF were
analyzed

Bersten, A. D.,
(2011)

Editorial based
off Keenan study
below

Key points
gleaned from
guidelines for
implementation
of NIV

Brambilla, A.
M., et al.,
(2019)

Evaluation of the
use of NIV in
ARF due to

347 from 19
centers in Italy
experiencing

promising new
interface for NIV.
Systematic
The use of NIV in
review
hypoxemia related
to pneumonia
resulted in
significantly lower
intubation rates,
hospital mortality,
and complications.
Early initiation of
NIV is most
successful. The
strongest evidence
for use involves
exacerbation of
COPD, as many
studies have
focused on this
disease process.
Compilation of
Successful
key points found implementation of
in the referred
NIV requires 24review.
hour availability of
experienced team
members and
monitoring for
failure to respond
and intubation
when indicated.
Observational
CPAP more often
study of the
used for hypoxemic
treatment of
nonhypercapnic

Level I
systematic
review

Includes the
results of many
RCTs and also
meta-analyses

Yes. NIV use
in pneumonia
is a significant
piece of the
protocol

Level VII
Expert opinion
of researcher

Support for welltrained team but
presented as
opinion

Yes. Support
for training of
staff and
providers in
management of
care

Level IV
Observational
study of two

The sample size
and multiple
center aspects of

Yes.
CPAP could be
trialed with
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pneumonia
outside the ICU,
and identification
of in-hospital
mortality risk
factors

Burns, K. E.
A., Meade M.
O., Premji A.,
Adhikari, N. K.
J., (2013)

ARF associated
with pneumonia

Examination of
Sixteen studies
studies involving analyzed by four
weaning from
researchers
intubation and
mechanical
ventilation to
NPPV versus
intermittent
positive-pressure
ventilation (IPPV)
weaning.
Reduction of
mortality,
weaning failure,
ventilatorassociated
pneumonia, ICU
and total length of
stay, duration of
mechanical

pneumonia
patients with
ARF and use of
NIV. CPAP
applied to 176
patients and
NPPV for 171.
Patient blood
gas results were
monitored, as
well as inhospital
mortality
Systematic
review

ARF. CPAP failure
would often
respond to NPPV
and prevent the
need for intubation.
Mortality rates
appeared to be
associated with the
patient’s baseline
status.

treatment
options across
19 facilities

this study
increase its
validity. The
authors concede
that the facilities
of study are
experienced in
the use of NIV.

nonhypercapnic
patients.

NPPV significantly
reduced mortality
and weaning
failure. ICU and
hospital LOS was
also reduced along
with duration of
mechanical and
noninvasive
ventilation.
Reduced risk of
VAP without
increased risk of
failure to wean or
reintubation was
also noted.

Level I
systematic
review

Sixteen RCTS
were analyzed
with
predominantly
COPD patients.
Effects in other
situations
requiring
ventilation
should also be
evaluated.

Yes.
Supports the
use of NPPV as
a method to
reduce
mortality and
complications
from intubation
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ventilation of
support, and
adverse events.
Burns, K. E.
Comparison of
A., Lellouch,
weaning times
L., Nisenbaum, using automated
R., Lessard, M. weaning and
R., Friedrich, J. spontaneous
O., (2014)
breathing trials
(SBTs) versus
non-automated
weaning
strategies in
invasively
ventilated
critically ill
adults.
Time to
successful
intubation, first
SBT and first
successful SBT,
mortality and
VAP rates, and
the LOS for ICU
and hospital were
also compared.
Cabrini, L. et
Evaluate early
al., (2019)
NIV for mildmoderate ARF in
non-ICU wards to
prevent severe
ARF.

10 trials with a
total of 654
participants
were examined

Systematic
review

Automated
weaning via the
SmartCare system
decreased weaning
time, time to
successful
extubation, and
LOS in ICU,
reducing the
percentage of
patients requiring
mechanical
ventilation for 7 or
21 days. These
benefits were
realized without
increased risk of
adverse events.

Level I
Systematic
review

Ten small trials
with low to
moderate quality
of evidence were
used to compile
data. A larger
trial, perhaps in
multiple
locations would
have been
preferable.

No. This
system is not
available in the
facility.

520 patients
with 260 in each
group
randomized to
receive NIV or
treatment as

Tracking of
development of
severe ARF, 28day mortality,
LOS, the safety
of NIV in non-

Trial is ongoing

Level II RCT

The sample size
is adequate to
inform practice

The results of
this study could
inform the
project but are
not yet
available.
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Digby, G. C.,
et al., (2015)

Description of
NIV practice
variation in the
acute setting

Esquinas, A.
Correspondence
M., et al.
regarding ED
correspondence

usual for mildmoderate ARF
330 patients
treated in 11
Canadian
tertiary care
centers using
NIV for ARF

ICU
environments
Collection of
data at each
facility during a
four-week
period. Data
collected
included times
locations,
indications and
initial settings
for NIV
initiation and
discontinuation.
Patient
characteristics,
ABGs upon
initiation, goals
of care (code
status) specialty
of ordering
provider, and
survival status
were also
recorded.

This was not a
research article,
rather discussion

Discussion
between two
groups

Wide variability in
NIV use among the
11 tertiary care
centers studied.
This variation
could be related to
lack of knowledge
or familiarity with
clinical practice
guidelines. COPD
and pulmonary
edema were the
two most common
diagnoses for
which NIV was
initiated and was
associated with
relativity fewer
intubations and
lower mortality
rates. Patients
receiving NIV for
ARF secondary to
pneumonia had a
higher rate of
intubation than the
previous two
diagnoses.
El-Khatib et al. had
investigated the
percentage of use

Level VI
Single
descriptive
qualitative
study

Descriptive study
with multiple
variables at play.
Provider
knowledge, and
location within
the facility
factored into the
choice and
timing of NIV

Yes.
Supports NIV
as method to
reduce
intubation

Level VII
Although this
Yes. This
professional
article documents supports the
correspondence the
need for
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with El-Khatib, protocols and use
M. F., et al.,
of NIV
(2014)

following an
investigation
into NIV use in
Lebanese EDs

interested in the
more
appropriate use
of NIV in the
ED environment

Keenan, S. P.,
et al., (2011)

An 18-member
panel of
clinicians
reviewed 146
RCTs
investigating
NIV. The panel
was formed by
the Canadian
Critical Trials
group and
Canadian
Critical Care

Systematic
review and
compilation of
NIV guidelines

Clinical practice
guidelines

of NIV in Lebanese
EDs and found
only 43% had some
form of protocol
for the use of NIV.
Esquinas et al.
called for
investigation into
the structure,
resources and
staffing of EDs, as
well as guidelines
for indication of
NIV based on
etiology, equipment
used, and training
of staff in
successful
application
NIV was shown to
reduce the need for
intubation and
hospital mortality.
Insufficient
evidence for
support with
asthma.
Lack of RCTs for
CAP with no
history of
respiratory disease
and NIV.

of expert
opinions

correspondence
between these
groups of
providers, valid
concerns are
raised that should
be considered in
the development
of a NIV
protocol.

protocols and
adequate
training of staff
and providers
in NIV use.

Level I
Systematic
review and
practice
guidelines

Global studies
investigated. The
research supports
use of NIV in
COPD and
cardiogenic
pulmonary
edema. Use of
NIV in patients
ARF may be
trialed, but
insufficient study
support for
recommendation.

Yes.
This supports
NIV in two
populations,
COPD and
cardiogenic
pulmonary
edema. At time
of study, lack
of evidence for
use in asthma
or pneumonia
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Society NIV
Guidelines

Kikichi, T. et
al., (2011)

Comparison of
protocol-based
noninvasive
positive-pressure
ventilation
(pNPPV) use in
the ED with
individual
physician directed
NPPV (iNPPV)

74 patients with
ARF seen in the
ED of one
facility

pNPPV protocol
was developed.
Data on 37
patients with
ARF treated
with iNPPV was
collected before
protocol
implementation,
and compared
with post
implementation
application of
pNPPV for 37
patients with
ARF.

Lim, W. J., et
al. (2012)

Determination of
the efficacy of
NPPV in adults
with severe acute
asthma in
comparison to
usual medical

Five studies
involving 206
participants
were reviewed

Comparison of
mortality and
tracheal
intubation rates,
as well as
changes in blood
gases and LOS

Acknowledge that
the possibility of
benefit for ARF
without COPD may
exist, but data had
not been collected
to support this at
the time of the
study.
The time to
intubation was
reduced in the
protocol-based
NPPV group and
hospital mortality
was significantly
lower. LOS was
shorter though not
statistically
significant.

The lack of studies
contributes to
continued
controversy
regarding NPPV in
asthma patients

Level VI
Single
qualitative
study

Single facility
study with
relatively small
sample.

Yes. This
supports the
creation of a
protocol for
NIV rather than
leaving
management up
to individual
providers
without
guidelines.

Level I
systematic
review with
only five
studies found
to include in
review

Very small
sample despite
being a review of
literature.
Contradictory
results continue
to flame the

Yes. Protocol
should exclude
asthma for NIV
use.
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Liu, Y. J.,
Zhao, J., Tang,
H., (2016)

Luo, Z., et al.,
(2018)

care with respect
to mortality,
tracheal
intubation,
changes in blood
gases, and LOS
Investigation of
the utility of
NPPV
intervention in
patients with ARF

Comparison of
High-intensity
versus lowintensity NPPV in
acute
exacerbation of
COPD
(AECOPD)

controversy
regarding NPPV
for asthma.

12 studies with a
total of 963
patients were
examined

600 patients
with AECOPD
recruited in 27
respiratory units
in university
hospitals in
China between
December 2017
and December
2018

Assessment of
the effectiveness
of NPPV versus
conventional
mechanical
ventilation
and/or nonventilation
therapy,
mortality rates,
and LOS in ICU
and hospital
Randomization
of eligible
participants into
high and low
intensity groups.
Tracking of the
need for
endotracheal
intubation,
decrement of
CO2 tension 2
hours after
therapy, as well
as in-house, 28day and 90-day

Usage of NPPV
Level I metawas associated with analysis of
significantly
studies
decreased
intubation and ICU
mortality rates, but
did not influence
the hospital
mortality rate, or
ICU or hospital
LOS.

Sample size and
characteristics
support the
validity of the
meta-analysis

Yes.
Further support
for reduction of
intubation rates

Study results not
yet available at the
time of publishing

This seems to be
a well-designed
study, and the
results could
inform a NPPV
protocol, but
those results are
not yet available.

No results to
inform project

Level II Well
designed RCT
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Meeder, A. M.,
Tjan, D., H. T.,
van Zanten, A.
R., (2016)

Assessment of
rates and
predictors of
NPPV failure and
comparison
hospital outcomes
of patients with
NPPV failure and
those intubated
without NPPV
trial

The records of
40 ARF patients
treated with
NPPV and 40
primary
intubation
patients in an
ICU in the
Netherlands

Ni, Y. N.,
Wang, T., Yu,
H., Liang, B.
M., Liang, Z.
A., (2017)

Determine the
effect of sedation
and/or analgesia
as rescue during
NPPV in patients
with interface
intolerance after
extubation

80 patients
placed on NPPV
post extubation
with
documented
interface
intolerance were
included.
Patients studied
were admitted to
7 ICUs of one
West China

mortality rates
will be
documented.
A retrospective
observational
study using data
from patients
with ARF
admitted to ICU
from 2013-2014.
All NPPV
patients were
evaluated and a
sample of
primarily
intubated
patients were
selected for
comparison of
survival rates
and risk factors.
41 of 80 patients
received
sedation and/or
analgesia during
the NPPV
therapy.

Patients with ARF
who fail NPPV
have worse
outcomes than
those with
successful NPPV.
NPPV failure
patients do not
have improved
outcomes over
primarily intubated
patients. A
prospective trial of
NPPV is warranted
in ARF.

Level IV
retrospective
observational
case-control
study

Single center
study. Would
need replicated
studies for
increased validity

Yes.
NPPV
significantly
reduces need
for intubation
and a trial with
failed NPPV
does not impact
outcomes.

The patients
receiving sedation
and/or analgesia
evidenced a
decrease in
respiratory failure
(15% vs. 38%), and
mortality rate (7%
vs. 33%), and
length of ICU stay
after extubation.

Level IV welldesigned casecontrol study.
A retrospective
study of the
effect of
analgesia on
NPPV
tolerance.

Relatively small
sample of 80
patients in one
facility in China.

Yes.
Sedation or
analgesia could
be included in
the NIV
protocol for
interface
intolerance
during
weaning.
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Osadnik, C.R.,
et al. (2017)

Comparison of
the efficacy of
NIV versus no
mechanical
ventilation in
adults with acute
hypercapnic
respiratory failure
(AHRF) due to
AECOPD

Ouellette, D.
R., et al.
(2017)

Development of
practice
guidelines and
protocols for
mechanical
ventilation

facility between
December 2014
and August
2016.
1264 patients
from 17 clinical
trials

Multiple studies
were included to
answer three
PICO questions

Evaluation of
mortality rates,
intubation rates,
and LOS were
compared
through the
studies for
AECOPD
patients
receiving NIV
and those who
did not.

The risk of death
was reduced by
46% and the
necessity of
intubation was
reduced by 65% in
NIV patients. NIV
patients showed an
average 3.4 days
shorter LOS than
those not receiving
NIV.

Level I
Systematic
review of 17
clinical trials

1st Should SBT
be conducted
with or without
inspiratory
pressure
augmentation?
2nd does
minimizing
sedation impact
duration of
ventilation?
3rd How does
NIV compare
with no NIV
post extubation
in duration of

1st For patients
ventilated more
than 24 hours,
initial SBT should
be conducted with
inspiratory pressure
augmentation
(CPAP) rather than
without.
2nd For patients
ventilated more
than 24 hours,
protocols for
minimal sedation
should be
implemented

Level I
Clinical
practice
guideline post
Meta-analysis
of available
literature

Though the
findings scored
as moderate on
the GRADE
criteria, the
number of
patients included
and the number
of facilities
studied support
the
generalizability
of the results.
Although this is a
joint clinical
practice
guideline from
the American
College of Chest
Physicians and
the American
Thoracic Society,
each of the three
questions was
addressed by
review of 5-6
clinical trials.

Yes.
Support for
NIV over
withholding of
the therapy

Yes.
These are
official
guidelines to
inform the
protocol
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ventilation,
extubation
success,
duration of ICU
stay and short or
long-term
mortality?

3rd For patients at
high risk for
extubation failure,
preventative NIV is
recommended post
extubation.

NPPV can be
successful in
reducing the
intubation rate but
should be carried
out by skilled
teams that can
recognize failure
and the need for
intubation, or
discussion with
patient and family
regarding wishes
for DNI status early
in treatment.
PT may reduce the
workload of nurses
and physicians in
management of
NIV/CPAP.

Scala, R.,
Pisani, L.,
(2018)

Update on
evidence-based
usefulness of
NPPV in ARF

116 articles
listed in
references

A qualitative
review and
analysis of
studies

Simonelli, C.,
Paneroni, M.,
Vitacca, M.,
(2013)

Description of
implementation of
a standardized
protocol to NIV
adaptation for
patients with
chronic
respiratory
disease, and
evaluation of the

201 chronic
respiratory
disease patients
were enrolled in
cardiopulmonary
rehabilitation
service (CPRS)
over 16 months
in one Italian
hospital

Measurement of
the effectiveness
of PT in
management of
NIV/CPAP

Level V
A qualitative
review

No specific
recommendations
or changes
provided for an
NIV protocol.
Discussion of the
need for skilled
practitioners to
know when and
which NIV to
use, which
interface, and
which settings.

No, the
effectiveness of
NIV is not
discussed. The
need for skilled
practitioners is
the focus of the
study.

Level VI
One qualitative
study in one
Italian hospital

Evidence from a
single study. The
role of
physiotherapist is
more commonly
used in rehab
setting rather
than acute care.

No. The facility
does not have a
physiotherapist
available for
this role.
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Stefan, M., S.,
et al., (2018)

Vargas, F., et
al., (2017)

physiotherapist
(PT) role and
time-consumption
Comparison of
patients
hospitalized with
pneumonia
treated with NIV
and invasive
mechanical
ventilation (IMV)

Assessment of the
efficacy of early
NIV in decreasing
respiratory failure
after extubation in
patients with
chronic
respiratory
disorders

3971 medical
records mined
from the Cerner
EHR system

A retrospectivecohort study
comparing ARF
pneumonia
patients placed
on NIV or IMV
or both during
their course of
treatment

144
mechanically
ventilated
patients with
chronic
respiratory
disorder in six
French ICUs
between January
2010 and June
2011

Prospective
randomized
multicenter
controlled trials
were randomly
assigned to
receive NIV
post extubation
or conventional
oxygen therapy.
72 patients were
assigned to each

Initial NIV was
associated with
better survival
among the
subgroup of
patients
hospitalized with
pneumonia who
had COPD or heart
failure. Patients
who failed NIV had
a high in-hospital
mortality,
emphasizing the
importance of
careful
management of
NIV.
Respiratory failure
for the NIV group
was 8.5%
compared to 27.8%
for the oxygen
group. Reintubation
occurred in 8.5% of
NIV and 18.1 % of
oxygen group.
Mortality rates did
not differ
significantly

Level IV
Retrospective
cohort study

Very large
sample from a
wide variety of
locations in the
United States

Yes.
NIV improved
survival rate for
pneumonia.

Level II
A welldesigned
multicenter
RCT

144 patients from
six facilities were
included in the
study. The
facilities were all
in France and
should be
supported by
replication in
other countries.

Yes. NIV is
supported as
reducing
respiratory
failure in
chronic
respiratory
disease.
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group.
between the
Respiratory
groups.
failure after
extubation,
reintubation,
ICU mortality
and 90-day
mortality were
tracked for both
groups.
*Note: Melnyk’s Level of Evidence (LOE) Pyramid is required for appraising the level of evidence. This appendix is formatted in landscape
orientation.
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Appendix: B Noninvasive Ventilation (NIV) Pilot Protocol
Initial patient assessment of the need for NIV
Inclusion

Exclusion
Yes

Acute COPD, CPE, or hypercapnic respiratory failure
(pH< 7.35 and PaCO2>45 mmHg)
Hypoxemia SpO2< 90% or PaO2< 80 *
Clinical signs of impending intubation, including but not limited to:
Tachypnea of ≥25 breaths/minute, increased respiratory effort or
fatigue, dyspnea, accessory muscle use, intercostal retractions, or
paradoxical abdominal movement.

Apnea
Unable to cooperate
Need for airway protection (coma., seizures vomiting)
SBP < 90mm HG
Recent facial, esophageal, or gastric surgery or trauma
Facial deformities preventing effective seal
Inability to clear secretions

No

Yes

Monitor
Initial Settings
Patient comfort, dyspnea, accessory muscle use
Respiratory rate and SpO2
Heart Rate & blood pressure
Patient-ventilator synchrony
Mask leak
Arterial Blood Gases (ABGs) at 60 minutes
Monitor for signs of gastric distension
Assess drying of eyes
Assess for facial skin breakdown

Obtain orders for NIV protocol
Oronasal mask for pressure support ventilation
Titrate FIO2 for SpO2> 90% *
Telemetry with SaO2 monitor

Adjustment to improve patient compliance
Coaching
Mask fit; Nasal versus oronasal
Inspiratory and expiratory pressure
levels
FIO2 level
Sedation
Continuous versus intermittent use

No

Yes

Consider intubation

NIV Failure

Hemodynamic instability
Decreased mental status
Respiratory rate ≥ 25
Decreasing pH and increasing PaCO2
Inability to maintain SpO2> 90% *
Inability to tolerate mask
Inability to manage secretions
Patient preference

f
12-hour rest on NIV if tolerated
Repeat ABG in 12 hours and every 24
hours if stable
Continue monitoring for evidence of
NIV failure
Titrate inspiratory and expiratory
positive pressure as tolerated to maintain
FIO2 for SpO2 ≥90%

Monitor for signs of fatigue
Resume NIV for the following:
Respiratory rate > 25/minute
Increased dyspnea
Increased use of accessory muscles
Patient request

No

Discontinue NIV
Yes
Free from NIV for 24
hours without fatigue

Trials off NIV as tolerated
*Goal O2 saturation may vary in COPD patients. Adjust per provider orders or patient baseline
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Appendix C: NIV Audit Tool
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Appendix D: Letter of Permission from Facility of Study

Brownwood Regional
MEDICALCENTER
January 11, 2019
Liberty University
ATTENTION: FAITH STERLING
C/O Dr. Kopis
1971 University Blvd.
Lynchburg, VA 24515
Re: Janise Tinsman DNP
To Whom it May Concern:
My name is Misty Woodard. I am the Facility Compliance Officer and Director of Quality Management and Regulatory Compliance for
Brownwood Regional Medical Center in Brownwood, Texas. Janise Tinsman is a student enrolled in your DNP program and is slated to begin her
course work on January 14, 2019. l, along with William Loyd, will serve as her preceptors for the program.
Please accept this written notice permitting Ms. Tinsman to perform duties pursuant to your NonExclusive Student Affiliation Agreement with
our facility. On behalf of our facility, Mr. Loyd and I are excited to begin work on reducing mortality and improving the overall care of the
pneumonia patient population.
Ms. Tinsman will be performing medical record reviews for data collection, working with a team to implement protocols and order sets, and will
be leading a collaborative for a successful implementation of these new protocols.
If you have any further needs, please do not hesitate to contact myself or Mr. Loyd at the contact information below.
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Sincerely,

Misty D. Woodard, RN, BSN
FCO, Director of QMRC
Misty_Woodard@BRMC-Cares.com

William Loyd, BBA, SHA
Director of Operations
William_Loyd@BRMC-Cares.com
325-649-3315

1501 Burnet Drive Brownwood, TX 76801 325 646 8541 • brmc-cares.com
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Appendix E: Permission to Use Iowa Model

Permission to Use The Iowa Model Revised: Evidence-Based
Practice to Promote Excellence in Health Care
K
Kimberly Jordan - University of Iowa Hospitals and Clinics <noreply@qualtricssurvey.com>

Reply all|
Sun 1/27, 6:32 PM
Tinsman, Janise
Inbox

Action Items

You have permission, as requested today, to review and/or reproduce The Iowa Model Revised:
Evidence-Based Practice to Promote Excellence in Health Care. Click the link below to open.
The Iowa Model Revised: Evidence-Based Practice to Promote Excellence in Health Care
Copyright is retained by University of Iowa Hospitals and Clinics. Permission is not granted
for placing on the internet.
Citation: Iowa Model Collaborative. (2017). Iowa model of evidence-based practice:
Revisions and validation. Worldviews on Evidence-Based Nursing, 14(3), 175-182.
doi:10.1111/wvn.12223
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In written material, please add the following statement:
Used/reprinted with permission from the University of Iowa Hospitals and
Clinics, copyright 2015. For permission to use or reproduce, please contact the
University of Iowa Hospitals and Clinics at 319-384-9098.
Please contact UIHCNursingResearchandEBP@uiowa.edu or 319-384-9098 with questions.
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Appendix F:.CITI Training Certificate
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Appendix G: Historical Results
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Appendix H: Protocol Results
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